Adial Pharmaceuticals (ADIL) vs MetaVia (MTVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Adial Pharmaceuticals is the larger company by market cap ($10.6 million vs $9.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ADIL | MTVA |
|---|---|---|
| Share price | $4.05 | $1.39 |
| Market cap | $10.63M | $9.16M |
| 1-day change | +1.50% | -4.80% |
| YTD return | -27.45% | — |
| 1-year return | -59.08% | — |
| 5-year return | -99.84% | — |
| EPS (TTM) | $-20.65 | $-3.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.75 | $14.85 |
| 52-week low | $1.31 | $0.966 |
| Distance from 52-week high | -62.33% | -90.64% |
| Average volume | 56.77K | 230.88K |
| Shares outstanding | 2.63M | 6.59M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ADIL vs MTVA FAQ
Which is bigger, Adial Pharmaceuticals or MetaVia?
Adial Pharmaceuticals (ADIL) is larger, with a market capitalization of $10.63M compared with $9.16M for MetaVia (MTVA).
Are Adial Pharmaceuticals and MetaVia in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.